The answer emerged from multiple recent studies that identified highly neurotoxic soluble aggregates of amyloid, called Aβ oligomers (oligomers), as upstream drivers of AD pathogenesis that lead to tau hyperphosphorylation and aggregation in NFTs, synaptic injury, and neuronal loss [5,6,7]. This evidence concerns the gene MAPT and Alzheimer disease.